The FDA announced on April 4, 2014, that Boehringer Ingelheim Roxane Inc voluntarily recalled Azathioprine Tablets USP, 50 mg, due to labeling errors where expiration dates were incorrectly set to 36 months instead of the filed 24 months. The agency said the recall affects 8,304 bottles distributed nationwide.
How to tell if you have it
- Brand: Roxanne Laboratories
- Product: Azathioprine Tablets USP 50 mg
- Packaging: 100 count bottle
- NDC: 0054-4084-25
- Lot code: 261983A
- Incorrect expiration date shown: 11/15
The hazard
The recall is due to incorrect or missing lot and expiration dates on the label. The product was given 36-month expiration dates instead of the filed 24 months, according to the FDA.
Context
GovInfoNow's records show Boehringer Ingelheim Roxane Inc has had 12 other recalls since November 5, 2012. Recent brand recalls include a September 25, 2015 recall of FUROSEMIDE Tablets USP due to CGMP deviations and an April 2, 2015 recall of Acarbose 50mg Tablets for low potency. Other recent recalls of similar products include OurPharma Fentanyl Injection Recall (September 3, 2026), American Regent Levocarnitine Injection Recall (April 16, 2026), and Ajanta Pharma Recalls Ranolazine 1000mg (September 17, 2026).